{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:31:56Z","timestamp":1764401516027},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/inf.0b013e31818e0e2e","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T14:27:14Z","timestamp":1242916034000},"page":"277-282","source":"Crossref","is-referenced-by-count":41,"title":["Serotype Coverage of Invasive and Mucosal Pneumococcal Disease in Israeli Children Younger Than 3 Years by Various Pneumococcal Conjugate Vaccines"],"prefix":"10.1097","volume":"28","author":[{"given":"Dror S.","family":"Shouval","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noga","family":"Givon-Lavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurith","family":"Porat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R2-4-20210202","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"key":"R3-4-20210202","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1542\/peds.2006-2138","article-title":"Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine.","volume":"119","author":"Poehling","year":"2007","journal-title":"Pediatrics"},{"key":"R4-4-20210202","article-title":"Statistical Abstracts of Israel, 1998. No. 49.","year":"1998"},{"key":"R5-4-20210202","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00006454-199305000-00006","article-title":"Hospitalization of Jewish and Bedouin infants in southern Israel for bronchiolitis caused by respiratory syncytial virus.","volume":"12","author":"Dagan","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"R6-4-20210202","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/321874","article-title":"A decade (1989\u20131998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice.","volume":"33","author":"Fraser","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R7-4-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R9-4-20210202","first-page":"699","article-title":"The quellung reaction, a neglected microbiologic technique.","volume":"43","author":"Austrian","year":"1976","journal-title":"Mt Sinai J Med"},{"key":"R10-4-20210202","article-title":"Performance standards for antimicrobial susceptibility testing: fourteenth informational supplement.","year":"2004"},{"key":"R11-4-20210202","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0732-8893(92)90093-9","article-title":"Evaluation of the E-Test for susceptibility testing of pneumococci.","volume":"15","author":"Jacobs","year":"1992","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R12-4-20210202","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.vaccine.2007.06.004","article-title":"Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults.","volume":"25","author":"Scott","year":"2007","journal-title":"Vaccine"},{"key":"R14-4-20210202","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media.","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"R15-4-20210202","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/378744","article-title":"Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.","volume":"37","author":"Kilpi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R16-4-20210202","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"R17-4-20210202","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1086\/431679","article-title":"Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus.","volume":"192","author":"Dagan","year":"2005","journal-title":"J Infect Dis"},{"key":"R18-4-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(06)70520-5","article-title":"Streptococcus pneumoniae in Western Europe: serotype distribution and incidence in children less than 2 years old.","volume":"6","author":"Jefferson","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"R19-4-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes.","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R20-4-20210202","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"R21-4-20210202","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/mdr.2005.11.195","article-title":"Serotypes and clonal types of penicillin-susceptible Streptococcus pneumoniae causing invasive disease in children in five Latin American countries.","volume":"11","author":"Zemlickova","year":"2005","journal-title":"Microb Drug Resist"},{"key":"R22-4-20210202","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2006.09.009","article-title":"The roles of pneumococcal serotypes 1 and 5 in pediatric invasive disease.","volume":"25","author":"Hausdorff","year":"2007","journal-title":"Vaccine"},{"key":"R23-4-20210202","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/01.inf.0000220231.79968.f6","article-title":"Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media, and acute conjunctivitis.","volume":"25","author":"Shouval","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R24-4-20210202","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/INF.0b013e31816fca86","article-title":"An international serotype 3 clone causing pediatric noninvasive infections in Israel, Costa Rica, and Lithuania.","volume":"27","author":"Porat","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R25-4-20210202","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1086\/502680","article-title":"Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids.","volume":"42","author":"Le Monnier","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"R26-4-20210202","first-page":"55","article-title":"The features of Haemophilus influenzae and Streptococcus pneumoniae carriage and the comparative characteristics of strains isolated from healthy children and from patients with acute and chronic respiratory infections.","author":"Katosova","year":"1994","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"R27-4-20210202","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/586747","article-title":"Pneumococcal necrotizing pneumonia in Utah: does serotype matter?","volume":"46","author":"Bender","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R29-4-20210202","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/INF.0b013e31805cdbeb","article-title":"Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.","volume":"26","author":"Messina","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R30-4-20210202","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA"},{"key":"R31-4-20210202","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1086\/429908","article-title":"Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine.","volume":"40","author":"McEllistrem","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R32-4-20210202","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"R33-4-20210202","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.298.15.1772","article-title":"Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.","volume":"298","author":"Pichichero","year":"2007","journal-title":"JAMA"},{"key":"R35-4-20210202","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3201\/eid1402.070807","article-title":"Streptococcus pneumoniae serotype 19A in children, South Korea.","volume":"14","author":"Choi","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"R36-4-20210202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"R37-4-20210202","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/503805","article-title":"Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.","volume":"193","author":"Hammitt","year":"2006","journal-title":"J Infect Dis"},{"key":"R38-4-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-144-1-200601030-00004","article-title":"Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization.","volume":"144","author":"Flannery","year":"2006","journal-title":"Ann Intern Med"},{"key":"R39-4-20210202","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1086\/425422","article-title":"Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska.","volume":"190","author":"Moore","year":"2004","journal-title":"J Infect Dis"},{"key":"R40-4-20210202","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004.","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-200904000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:04:10Z","timestamp":1618279450000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-200904000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31818e0e2e","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}